4
Changes in Ownership
Emergent BioSolutions Inc. Filed Acc 0001583098-26-000004
Director sold 15,481 shares at an average $8.40 ($129,994)
- Director acquired 25,344 shares (grant or award)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
DeGolyer Donald W · Director
Table I: Non-derivative
3 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-04-30 | Grant or award : show line 1 in the form 10b5-1 | +25,344 | 145,202 | D | ||
| 2026-05-01 | Sale : show line 2 in the form 10b5-1 | −14,527 | $8.36 | $121,446 | 130,675 | D |
| 2026-05-01 | Sale : show line 3 in the form 10b5-1 | −954 | $8.96 | $8,548 | 129,721 | D |
| Open-market sales · 15,481 sh · avg $8.40 · $129,994 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-04-30 | Grant or award : show line 4 in the form 10b5-1 Stock Option (Right to Buy) | +11,296 | 11,296 | D |
Loading xslF345X06/wk-form4_1777930221.xml…